[1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Sudarshan Murthy und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biochemistry and Molecular Medicine and Biocenter Oulu, University of Oulu, Oulu90220, Finland. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Tankyrases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sigrid Jus?liuksen S??ti?, Deutsche Forschungsgemeinschaft, Jane ja Aatos Erkon S??ti?.
Abstract (Originalsprache)
We report [1,2,4]triazolo[3,4-b]benzothiazole (TBT) as a new inhibitor scaffold, which competes with nicotinamide in the binding pocket of human poly- and mono-ADP-ribosylating enzymes. The binding mode was studied through analogues and cocrystal structures with TNKS2, PARP2, PARP14, and PARP15. Based on the substitution pattern, we were able to identify 3-amino derivatives 21 (OUL243) and 27 (OUL232) as inhibitors of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15 at nM potencies, with 27 being the most potent PARP10 inhibitor described to date (IC50 of 7.8 nM) and the first PARP12 inhibitor ever reported. On the contrary, hydroxy derivative 16 (OUL245) inhibits poly-ARTs with a selectivity toward PARP2. The scaffold does not possess inherent cell toxicity, and the inhibitors can enter cells and engage with the target protein. This, together with favorable ADME properties, demonstrates the potential of TBT scaffold for future drug development efforts toward selective inhibitors against specific enzymes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Biochemistry and Molecular Medicine and Biocenter Oulu, University of Oulu, Oulu90220, Finland.
- Department of Pharmaceutical Sciences, University of Perugia, Perugia06123, Italy.
- Institute of Biochemistry and Molecular Biology, RWTH Aachen University, Aachen52074, Germany.
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, SienaI-53100, Italy.
ORCID-Profile: Serena Massari, Yashwanth Ashok, Harikanth Venkannagari, Bernhard Lüscher, Oriana Tabarrini, Lari Lehtiö
Förderung
- Sigrid Jus?liuksen S??ti?
- Deutsche Forschungsgemeinschaft
- Jane ja Aatos Erkon S??ti?
- Magnus Ehrnroothin S??ti?
Zitieren
APA
Murthy, S., Nizi, M. G., Maksimainen, M. M., Massari, S., Alaviuhkola, J., Lippok, B. E., Vagaggini, C., Sowa, S. T., Galera-Prat, A., Ashok, Y., Venkannagari, H., Prunskaite-Hyyryläinen, R., Dreassi, E., Lüscher, B., Korn, P., Tabarrini, O., & Lehtiö, L. (2023). [1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01460
Vancouver
Murthy S, Nizi MG, Maksimainen MM, Massari S, Alaviuhkola J, Lippok BE, et al. [1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01460
BibTeX
@article{Murthy2023,
author = {Murthy, Sudarshan and Nizi, Maria Giulia and Maksimainen, Mirko M and Massari, Serena and Alaviuhkola, Juho and Lippok, Barbara E and Vagaggini, Chiara and Sowa, Sven T and Galera-Prat, Albert and Ashok, Yashwanth and Venkannagari, Harikanth and Prunskaite-Hyyryläinen, Renata and Dreassi, Elena and Lüscher, Bernhard and Korn, Patricia and Tabarrini, Oriana and Lehtiö, Lari},
title = {[1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01460}
}
EUVIMED